S-ethyl N-[4-(trifluoromethyl)phenyl] Isothiourea (hydrochloride)
| 规格 | 价格 | 货期 | 数量 |
|---|---|---|---|
| 10mg | ¥1083.00 | 10-15工作日发货 | |
| 25mg | ¥2329.00 | 10-15工作日发货 | |
| 100mg | ¥6337.00 | 10-15工作日发货 |
特色产品
- 用于免疫印迹和质谱分析等后续操作
- 适用于30 KDa-130 KDa大小的蛋白
- 可将信号灵敏度提高100倍
- 同时保持稳定的特异性和分辨率
- 提供更高的转录效率并抑制免疫激活
- 使用5-moUTP和Cy5-utp修饰
产品描述
S-ethyl N-[4-(trifluoromethyl)phenyl] Isothiourea (hydrochloride) is a selective and competitive nNOS inhibitor with Ki value of 0.32 μM for the purified human enzyme [1].
Nitric oxide (NO) is an endogenously produced inorganic free radical gas which has been implicated in blood pressure homeostasis, platelet aggregation, neurotransmission, and immunological defense mechanisms. NO is synthesized by three isoforms of nitric oxide synthase (NOS): nNOS, eNOS and iNOS [1].
S-ethyl N-[4-(trifluoromethyl)phenyl] Isothiourea (hydrochloride) (EPIT) is a selective and competitive nNOS inhibitor. S-ethyl N-[4-(trifluoromethyl)phenyl] Isothiourea inhibited human nNOS, eNOS and iNOS with Ki values of 0.32 μM, 9.4 μM and 37 μM, respectively. EPIT exhibited 115-fold and 29-fold selectivity for nNOS compared to iNOS and eNOS, respectively [1].
In mice, EPIT administered intravenously at 25 mg/kg readily penetrated the blood-brain barrier, immediately reaching concentrations in the brain equal to the plasma concentration. In rat brain slices, EPIT failed to inhibit nNOS activity, possibly due to reduced intracellular uptake [1].
Reference:
[1]. Shearer BG, Lee S, Oplinger JA, et al. Substituted N-phenylisothioureas: potent inhibitors of human nitric oxide synthase with neuronal isoform selectivity. J Med Chem. 1997 Jun 6;40(12):1901-5.
产品性质
| 物理外观 | A crystalline solid |
| CAS号 | 163490-78-6 |
| 分子式 | C10H11F3N2S·HCl |
| 分子量 | 284.7 |
| 小分子别名 | hnNOS-IN-3 |
| 化学名称 | ethyl[4-(trifluoromethyl)phenyl] carbamimidothioate, hydrochloride |
| 溶解度 | ≤34mg/ml in ethanol;34mg/ml in DMSO;34mg/ml in dimethyl formamide;50mg/ml in H2O |
| SMILES | CCSC(Nc1ccc(C(F)(F)F)cc1)=N.Cl |
| 存储条件 | -20°C |
| 运输条件 | 蓝冰 |
产品应用 (实验数据来自文献,APExBIO并未验证,仅供参考)
IC50和靶点
| 生物活性描述 | hnNOS-IN-3 (化合物 39)是一种选择性抑制剂,其抑制浓度为 0.32 μM。hnNOS-IN-3 与 nNOS 的结合与 L-精氨酸具有竞争性。相对于 iNOS(=37 μM)和 eNOS(=9.4 μM),hnNOS-IN-3 对 nNOS 的选择性分别为 115 倍和 29 倍。 |



沪公网安备 31011002003500